Please login first

Pharmaceuticals Webinar | Recent Advances in Ocular Pharmacology

Part of the Pharmaceuticals Webinar series
4 June 2025, 20:00 (EEST)

ophthalmology, drug delivery, ocular barriers
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Welcome from the Chairs

4th Pharmaceuticals Webinar

Recent Advances in Ocular Pharmacology

We welcome you to this webinar which aims to present novel therapeutic substances and treatment modalities for ocular conditions. The eye’s unique characteristics (barriers, size, sensitivity of tissues and anatomical structures) render this discussion very interesting; at the same time, new substances are being developed to treat conditions that affect the eyesight and the quality of life of millions of patients. We hope that the presentations delivered by academics with extensive research in this field will contribute to the ongoing scientific dialogue in this significant field.

Date: 4 June 2025

Time: 1:00 pm EDT | 7:00 pm CEST | 8:00 pm EEST

Webinar ID: 813 1687 2025

Webinar Secretariat: journal.webinar@mdpi.com

Event Chairs

2nd University Eye Clinic, Medical School, Aristotle University of Thessaloniki, Greece

Introduction

Ophthalmica Institute

Introduction

Invited Speakers

1st Laboratory of Pharmacology, Medical School, Aristotle University of Thessaloniki, Greece

Introduction
Talk
Presentation Title: SPECIAL FEATURES OF OCULAR PHARMACOKINETICS

School of Pharmacy, Aristotle University of Thessaloniki, Greece

Introduction
Talk
Presentation: NOVEL NANO FORMULATIONS FOR THE TREATMENT OF GLAUCOMA
Bio
Dimitrios Fatouros is a Professor at Aristotle University of Thessaloniki School of Pharmacy. He holds a PhD in Pharmaceutical Technology from the School of Pharmacy at the University of Patras in Greece. He subsequently held posts as a Post-Doctoral fellow at the Leiden/Amsterdam Centre of Drug Delivery (LA/CDR) Research Assistant Professor at the Danish University of Pharmaceutical Sciences and Senior Lecturer at the University of Portsmouth, School of Pharmacy and Biomedical Sciences. His areas of research expertise cover advanced drug delivery systems, nanomedicine and nanotechnology with special focus on additive manufacturing, mucosal delivery, poorly soluble drugs, in vitro digestion models and self-assembling peptides. He has co-authored over 220 peer research articles and book chapters (google Scholar 7703, h index 49).

University of Tübingen, Germany

Introduction
Talk
Presentation Title: UTILIZATION OF NANOPARTICLES FOR TREATING AGE-RELATED MACULAR DEGENERATION
Bio
Dr. Anna Nikolaidou is a medical doctor and PhD candidate in Experimental Medicine at the University of Tübingen's Institute for Ophthalmic Research. She holds an MD and two MSc degrees in Medical Research Methodology from Aristotle University of Thessaloniki and in Nanomedicine from the National and Kapodistrian University of Athens. Her professional experience includes serving as an ophthalmology resident at Aghia Sophia Children's Hospital in Athens, and previously as a research fellow at the Laboratory of Experimental Ophthalmology at Aristotle University. Dr. Nikolaidou has authored over 10 peer-reviewed publications, focusing on pediatric ophthalmology, technology applications, and the integration of artificial intelligence in eye care. At the University of Tübingen, her PhD project focuses on myopia and the use of electrophysiology on understanding the underlying retinal mechanisms. Her Medical Doctoral project focuses on rehabilitation strategies for children with hemianopia.

University Eye Clinic, Greece,
University of Ioannina, Greece

Introduction
Talk
Presentation Title: FABRICATION OF A NOVEL HUMANISED MODEL OF THE INNER BLOOD RETINAL BARRIER
Bio
Dr. George Stergiopoulos is a 4th-year Ophthalmology resident at the University Eye Clinic of Ioannina. He received his MD from the University of Ioannina in 2018 and obtained an MSc in Biomedical Research Methodology, Biostatistics and Clinical Bioinformatics from the University of Thessaly in 2023. He is currently pursuing a PhD at the University of Ioannina in collaboration with FORTH-BRI, focusing on developing a humanised in vitro model of the retinal neurovascular unit using stem cell-derived retinal organoids and microfluidics, aiming to study diabetic retinopathy. His research proposal was one of the five selected for presentation at the Young Ophthalmologists' Research Dragons’ Den during the 58th National Ophthalmology Congress in 2025. Dr. Stergiopoulos has experience as a general practitioner in the private sector and has received two awards for oral presentations during his residency. He speaks English and German fluently.

Registration

This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.

Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.

Program

Speaker/Presentation

Time in EEST

Professor Ioannis Tsinopoulos

CHAIR INTRODUCTION

20:00-20:05

Dr Lampros Lamprogiannis

CHAIR INTRODUCTION

20:05-20:10

Professor Antonios Goulas

SPECIAL FEATURES OF OCULAR PHARMACOKINETICS

20:10-20:25

Professor Dimitrios Fatouros

NOVEL NANO FORMULATIONS FOR THE TREATMENT OF GLAUCOMA

20:25-20:40

Dr Anna Nikolaidou

UTILIZATION OF NANOPARTICLES FOR TREATING AGE-RELATED MACULAR DEGENERATION

20:40-20:55

Dr Georgios Stergiopoulos

FABRICATION OF A NOVEL HUMANISED MODEL OF THE INNER BLOOD RETINAL BARRIER

20:55-21:10

Q&A

21:10 -21:25

Professor Ioannis Tsinopoulos

CLOSING OF WEBINAR

21:25-21:30

Relevant Special Issue

Recent Advances in Ocular Pharmacology
Special Issue Editors: Dr. Lampros Lamprogiannis and Prof. Dr. Ioannis Tsinopoulos
Deadline for manuscript submissions: 31 July 2025

Sponsors and Partners

Organizers

Webinar Summary

Summary of the recording:

This webinar was an exciting opportunity to learn more about the fascinating pharmacokinetic properties of the eye and cutting-edge research on new treatment modalities for eye conditions affecting millions of people worldwide. As part of an ongoing effort to develop safer and more effective therapies for glaucoma, diabetic retinopathy, macular degeneration and other conditions, esteemed professors and emerging researchers shed light on ocular barriers and novel methods to overcome them.

This webinar was hosted via Zoom and required registration to attend. The full recording will be available below. To stay informed about future webinars, you can sign up for our newsletter by clicking "Subscribe" at the top of the page.

Top